Did CEOs and officers buy or sell their own stock?
Open-market trades by the people who know the company best, with their own money.
Last 7 days: the stocks insiders bought and sold most
Stocks Koreans hold most · disclosed Last 7 days · open-market trades only
Bought most
Sold most
Whalegun
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Fairmount Funds ManagementDirector | Cogent BiosciencesCOGT | Open-market sale | 03/31 | 03/31 | 7,000,000 sh | $34.66 | $242,620,000 | −56.0% |
Fairmount Funds ManagementDirector | Cogent BiosciencesCOGT | Open-market sale | 01/22 | 01/22 | 3,500,000 sh | $36.40 | $127,400,000 | −38.9% |
Cogent BiosciencesCOGT | Open-market sale | 25/12/26 | 25/12/30 | 77,000 sh | $38.68 | $2,978,360 | −36.9% | |
Evan KearnsChief Legal Officer | Cogent BiosciencesCOGT | Open-market sale | 25/12/26 | 25/12/30 | 65,000 sh | $38.70 | $2,515,500 | −37.3% |
Jessica SachsChief Medical Officer | Cogent BiosciencesCOGT | Open-market sale | 25/12/26 | 25/12/30 | 82,642 sh | $38.70 | $3,198,245.4 | −38.2% |
John Edward RobinsonChief Scientific Officer | Cogent BiosciencesCOGT | Open-market sale | 25/12/26 | 25/12/30 | 90,000 sh | $38.74 | $3,486,600 | −39.1% |
Fairmount Funds ManagementDirector | Cogent BiosciencesCOGT | Open-market buy | 25/07/10 | 25/07/14 | 2,777,777 sh | $9.00 | $24,999,993 | +44.6% |
Cole PinnowChief Commercial Officer | Cogent BiosciencesCOGT | Open-market buy | 25/01/14 | 25/01/15 | 43,750 sh | $7.60 | $332,500 | +2085.3% |
Fairmount Funds Management10% Owner | Cogent BiosciencesCOGT | Open-market buy | 23/06/09 | 23/06/13 | 800,000 sh | $12.00 | $9,600,000 | +32.4% |